Tecarfarin

DB12823InvestigationalSmall molecule

Tecarfarin has been used in trials studying the prevention of Thrombosis and Thromboembolism.

Mechanism: Pharmacologically active on Vitamin K epoxide reductase complex subunit 1
Curator reviewed
Formula / weight: C₂₁H₁₄F₆O₅ · 460.328 g/mol (avg)
Code names: ATI-5923

Resolves to

Compound

Structure

InChIKeyQFLNTQDOVCLQKW-UHFFFAOYSA-NSMILESCC(OC(=O)C1=CC=C(CC2=C(O)C3=CC=CC=C3OC2=O)C=C1)(C(F)(F)F)C(F)(F)F

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

17Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tecarfarin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.